What's breaking now, across thousands of outlets.
(MedPage Today) -- Use of GLP-1 receptor agonists was associated with increased cumulative gallbladder and biliary events in youths, according to a retrospective analysis of TriNetX data. Among over 37,000 adolescents and young adults with overweight...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
A 76-year-old man with prostate cancer has been detained by immigration officials for more than two months, relatives said.
(MedPage Today) -- Recent studies suggest that people with type 2 diabetes on GLP-1 receptor agonists were less likely to develop tuberculosis (TB) or be hospitalized or die from infections.
The CDC has tallied nearly 30,000 confirmed and probable cases this summer.
Side effects observed in testing have led Novartis to halt development of rap-cel in multiple indications and Bristol Myers to voluntarily pause its zola-cel program.
Kenya has secured a major breakthrough in cancer treatment after signing an agreement with US pharmaceutical giant Pfizer that will significantly reduce the cost of medicines used to treat several…
A new spatial transcriptomics framework compares tumor “floor plans." In a study of 262 solid tumors, the team identified recurring spatial groups that may connect spatial structure, biological…
